AnalystsAnthony ButlerAnthony Butler's Stock Forecasts
AnalystsAnthony Butler
Sectors:
Industries:
Analyst Ranking
Bottom 14%
#4211 out of 4871 analysts
Average Return
-47.04%
Win Rate
33%2 out of 6
Risk vs Reward
Poor
Good
Anthony Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aravive IncARAV | +48.76% | $1.21 | $1.80 | 2022-06-02 - 2023-06-02 | Strong Buy |
Incyte CorpINCY | +14.46% | $68.06 | $77.90 | 2019-01-02 - 2020-01-03 | Strong Buy |
Anthony Butler Analyst Color
Get additional color on Anthony Butler's coverage of popular stocks
Anthony Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Atara Biotherapeutics IncATRA | 2 | Strong Buy | $625.00 | N/A | Reiterates | 2 years ago |
Rain Oncology IncRAIN2 | 1 | Strong Buy | $16.00 | N/A | Reiterates | 2 years ago |
Aravive IncARAV | 2 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Incyte CorpINCY | 2 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.